Table 2.
Outcome Measures of Objective Cognitive Performance and Results of Selected Clinical Trials.
| References | Measures | At the end of the intervention | Reevaluation at distance after the end of intervention |
|---|---|---|---|
| Hoogenhout et al 24 | VVLT SCWT, CST, and LDST | ns ns | No follow-up |
| Tsai et al 26 | ADAS-Cog MMSE SRT CDT | P < .05 in EG1 and EG2 P < .05 in EG1 and EG2 P < .05 in EG1, ns in EG2 ns in EG1, P < .05 in EG2 | After 6 weeks ns in EG1, P < .05 in EG2 ns in EG1 and EG2 P < .05 in EG1, ns in EG2 ns in EG1 and EG2 |
| van Hooren et al 28 | SCWT | ns | After 24 weeks ns |
| Small et al 25 | SRT COWAT | ns P = .015 | No follow-up |
| Valentijn et al 27 | VVLT total VVLT recall SST immediate recall SST delayed recall | ns P = .001 in EG1 vs CG; P = .002 in EG1 vs EG2 ns ns | No follow-up |
| Andrewes et al 23 | Face-naming test Prospective memory | P < .01 ns | No follow-up |
Abbreviations: VVLT, visual-verbal learning test; SCWT, Stroop color-word test; CST, concept shifting test; LDST, letter digit substitution test; ADAS-Cog, Alzheimer’s Disease Assessment Scale-Cognitive subscale; MMSE, Mini-Mental State Examination; SRT, selective reminding test; CDT, clock-drawing test; COWAT, controlled oral word association test; SST, short story test; EG, experimental group; CG, control group; ns, nonsignificant.